Traws Pharma (TRAW) Other Working Capital Changes (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Other Working Capital Changes of -$1000.0 for Q4 2025, up 98.21% year-over-year from -$504.5 in Q4 2024, and down 200.0% quarter-over-quarter from $1000.0 in Q3 2025.
Traws Pharma (TRAW) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Other Working Capital Changes for 9 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 98.21% year-over-year to -$1000.0; the TTM figure through Dec 2025 stood at -$2.8 million (down 1134.96% YoY), while the FY2025 annual figure was -$2.8 million, down 1134.96% from the prior year.
- Other Working Capital Changes slipped to -$1000.0 in Q4 2025 per TRAW's latest filing, from $1000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.0 million in Q3 2023 and bottomed at -$849000.0 in Q4 2025.
- Historically, Other Working Capital Changes has averaged $30176.5 across 5 years, with a median of $22000.0 in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 101.75% in 2025 and fell as far as 4696.49% in 2025.
- Traws Pharma's Other Working Capital Changes stood at -$56000.0 in 2021, then changed by 0.0% to -$56000.0 in 2022, then changed by 0.0% to -$56000.0 in 2023, then changed by 0.0% to -$56000.0 in 2024, then surged by 98.21% to -$1000.0 in 2025.
- Business Quant data shows TRAW's Other Working Capital Changes at -$1000.0 in Q4 2025, $1000.0 in Q3 2025, and -$2.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - |
| 10 | Traws Pharma | 5.54 Mn | 527,765.92 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 480,000.00 |
| Mar 31, 2026 | 480,000.00 |
| Mar 31, 2026 | 480,000.00 |
| Dec 31, 2025 | -849,000.00 |
| Dec 31, 2025 | -849,000.00 |
| Dec 31, 2025 | -849,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -774,000.00 |
| Mar 31, 2025 | -774,000.00 |
| Mar 31, 2025 | -774,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | -375,000.00 |
| Sep 30, 2024 | -375,000.00 |